Cognitive alterations in groups at risk for psychosis: Neutral markers of genetic risk or indicators of social disability?

Acta Psychiatrica Scandinavica

Volumn 116, Issue 4, 2007, Pages 253-262

  Jabben, N ^a   Van Os, J ^a,b   Janssen, I ^a,c   Versmissen, D ^a,c   Krabbendam, L ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Mondriaan Zorggroep   (Netherlands)

Author keywords

Endophenotypes; High risk; Neurocognition; Outcome; Psychosis

Indexed keywords

ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROPSYCHIATRY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOSIS; RISK ASSESSMENT; SOCIAL DISABILITY;

ADULT; COGNITION DISORDERS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOTIC DISORDERS; RISK FACTORS; SOCIAL ADJUSTMENT;

EID: 34548452067     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2006.00990.x     Document Type: Article

References (61)

1. Dollfus S, Lombardo C, Benali K et al. Executive/attentional cognitive functions in schizophrenic patients and their parents: a preliminary study. Schizophr Res 2002 53 : 93 99.
2. Zalla T, Joyce C, Szoke A et al. Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia. Psychiatry Res 2004 121 : 207 217.
3. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998 12 : 426 445.
4. Hughes C, Kumari V, Soni W et al. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr Res 2003 59 : 137 146.
5. Keefe RS, Silverman JM, Roitman SE et al. Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests. Psychiatry Res 1994 53 : 1 12.
6. Faraone SV, Seidman LJ, Kremen WS, Pepple JR, Lyons MJ, Tsuang MT. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a diagnostic efficiency analysis. J Abnorm Psychol 1995 104 : 286 304.
7. Faraone SV, Seidman LJ, Kremen WS, Toomey R, Pepple JR, Tsuang MT. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a 4-year follow-up study. J Abnorm Psychol 1999 108 : 176 181.
8. Krabbendam L, Marcelis M, Delespaul P, Jolles J, Van Os J. Single or multiple familial cognitive risk factors in schizophrenia Am J Med Genet 2001 105 : 183 188.
9. Voglmaier MM, Seidman LJ, Salisbury D, McCarley RW. Neuropsychological dysfunction in schizotypal personality disorder: a profile analysis. Biol Psychiatry 1997 41 : 530 540.
10. Dinn WM, Harris CL, Aycicegi A, Greene P, Andover MS. Positive and negative schizotypy in a student sample: neurocognitive and clinical correlates. Schizophr Res 2002 56 : 171 185.
11. Gottesman II., Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003 160 : 636 645.
12. Baxter RD, Liddle PF. Neuropsychological deficits associated with schizophrenic syndromes. Schizophr Res 1998 30 : 239 249.
13. Lucas S, Fitzgerald D, Redoblado-Hodge MA et al. Neuropsychological correlates of symptom profiles in first episode schizophrenia. Schizophr Res 2004 71 : 323 330.
14. Bilder RM, Goldman RS, Robinson D et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry 2000 157 : 549 559.
15. O'Leary DS, Flaum M, Kesler ML, Flashman LA, Arndt S, Andreasen NC. Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia. J Neuropsychiatry Clin Neurosci 2000 12 : 4 15.
16. Liddle PF, Morris DL. Schizophrenic syndromes and frontal lobe performance. Br J Psychiatry 1991 158 : 340 345.
17. Brazo P, Marie RM, Halbecq I et al. Cognitive patterns in subtypes of schizophrenia. Eur Psychiatry 2002 17 : 155 162.
18. Malla AK, Norman RM, Manchanda R, Townsend L. Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis. Psychol Med 2002 32 : 1109 1119.
19. Penades R, Gasto C, Boget T, Catalan R, Salamero M. Deficit in schizophrenia: the relationship between negative symptoms and neurocognition. Compr Psychiatry 2001 42 : 64 69.
20. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia Am J Psychiatry 1996 153 : 321 330.
21. Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 2004 72 : 41 51.
22. Lysaker PH, Bryson GJ, Davis LW, Bell MD. Relationship of impaired processing speed and flexibility of abstract thought to improvements in work performance over time in schizophrenia. Schizophr Res 2005 75 : 211 218.
23. Milev P, Ho BC, Arndt S, Andreasen NC. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 2005 162 : 495 506.
24. Dickinson D, Coursey RD. Independence and overlap among neurocognitive correlates of community functioning in schizophrenia. Schizophr Res 2002 56 : 161 170.
25. Johns LC, Van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev 2001 21 : 1125 1141.
26. Van Os J, Hanssen M, Bijl RV, Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population? Schizophr Res 2000 45 : 11 20.
27. Hanssen M, Krabbendam L, Vollema M, Delespaul P, Van Os J. Evidence for instrument and family-specific variation of subclinical psychosis dimensions in the general population. J Abnorm Psychol 2006 115 : 5 14.
28. Krabbendam L, Myin-Germeys I, Hanssen M, Van Os J. Familial covariation of the subclinical psychosis phenotype and verbal fluency in the general population. Schizophr Res 2005 74 : 37 41.
29. Tien AY, Costa PT, Eaton WW. Covariance of personality, neurocognition, and schizophrenia spectrum traits in the community. Schizophr Res 1992 7 : 149 158.
30. Stefanis NC, Hanssen M, Smirnis NK et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med 2002 32 : 347 358.
31. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978 35 : 773 782.
32. Hanssen M, Peeters F, Krabbendam L, Radstake S, Verdoux H, Van Os J. How psychotic are individuals with non-psychotic disorders Soc Psychiatry Psychiatr Epidemiol 2003 38 : 149 154.
33. Mc Guffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991 48 : 764 770.
34. Vink M, Jolles J. A new version of the Trail Making Test as an information processing task. J Clin Neuropsychol 1985 7 : 162.
35. Luteijn F, van der Ploeg FAE. Handleiding Groninger Intelligentietest (GIT) [Manual Groningen Intelligence Test]. Lisse, The Netherlands : Swets & Zeitlinger, 1983.
36. Wechsler D. Wechsler Adult Intelligence Scale. Revised. New York, NY : Psychological Corporation, 1981 : ?? ??.
37. Verdoux H, Van Os J. Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr Res 2002 54 : 59 65.
38. Andreasen NC. Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, IA : University of Iowa, 1984.
39. Andreasen NC. Scale for the Assessment of Negative Symptoms (SANS). Iowa City, IA : University of Iowa, 1983.
40. Liddle PF. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br J Psychiatry 1987 151 : 145 151.
41. Andreasen NC, Arndt S, Miller D, Flaum M, Nopoulos P. Correlational studies of the Scale for the Assessment of Negative Symptoms and the Scale for the Assessment of Positive Symptoms: an overview and update. Psychopathology 1995 28 : 7 17.
42. WHO. WHO coordinated multi-center study on the course and outcome of Schizophrenia. Geneva : WHO, 1992.
43. Tabachnick BG, Fidell LS. Using multivariate statistics, 3rd edn. New York : HarperCollins College Publishers, 1996.
44. Statacorp. STATA statistical software: release 9.0. Texas : College Station, 2005.
45. Kremen WS, Hoff AL. Neurocognitive deficits in the biological relatives of individuals with schizophrenia. In : Stone WS, ed. Early clinical intervention and prevention in schizophrenia. Totowa, NJ : Humana Press, 2004 : 133 158.
46. Siever LJ, Davis KL. The pathophysiology of schizophrenia disorders: perspectives from the spectrum. Am J Psychiatry 2004 161 : 398 413.
47. Hoff AL, Svetina C, Maurizio AM, Crow TJ, Spokes K, DeLisi LE. Familial cognitive deficits in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2005 133 : 43 49.
48. Sitskoorn MM, Aleman A, Ebisch SJ, Appels MC, Kahn RS. Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophr Res 2004 71 : 285 295.
49. Sharma T, Du Boulay G, Lewis S, Sigmundsson T, Gurling H, Murray R. The Maudsley Family Study. I: structural brain changes on magnetic resonance imaging in familial schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 1997 21 : 1297 1315.
50. Van Os J, Verdoux H, Maurice-Tison S et al. Self-reported psychosis-like symptoms and the continuum of psychosis. Soc Psychiatry Psychiatr Epidemiol 1999 34 : 459 463.
51. Heydebrand G, Weiser M, Rabinowitz J, Hoff AL, DeLisi LE, Csernansky JG. Correlates of cognitive deficits in first episode schizophrenia. Schizophr Res 2004 68 : 1 9.
52. Keefe RS, Bilder RM, Harvey PD et al. Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial. Neuropsychopharmacology 2006 31 : 2033 2046.
53. Kendler KS, McGuire M, Gruenberg AM, O'Hare A, Spellman M, Walsh D. The Roscommon Family Study. III. Schizophrenia-related personality disorders in relatives. Arch Gen Psychiatry 1993 50 : 781 788.
54. Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry 2000 57 : 1053 1058.
55. Chapman LJ, Chapman JP, Kwapil TR, Eckblad M, Zinser MC. Putatively psychosis-prone subjects 10 years later. J Abnorm Psychol 1994 103 : 171 183.
56. Hanssen M, Bak M, Bijl R, Vollebergh W, Van Os J. The incidence and outcome of subclinical psychotic experiences in the general population. Br J Clin Psychol 2005 44 : 181 191.
57. Van der Does AJ, Dingemans PM, Linszen DH, Nugter MA, Scholte WF. Symptoms, cognitive and social functioning in recent-onset schizophrenia: a longitudinal study. Schizophr Res 1996 19 : 61 71.
58. Verdoux H, Liraud F, Assens F, Abalan F, Van Os J. Social and clinical consequences of cognitive deficits in early psychosis: a two-year follow-up study of first-admitted patients. Schizophr Res 2002 56 : 149 159.
59. Holthausen EA, Wiersma D, Knegtering RH, Van den Bosch RJ. Psychopathology and cognition in schizophrenia spectrum disorders: the role of depressive symptoms. Schizophr Res 1999 39 : 65 71.
60. Rocca P, Bellino S, Calvarese P et al. Depressive and negative symptoms in schizophrenia: different effects on clinical features. Compr Psychiatry 2005 46 : 304 310.
61. Amador XF, David AS. Insight and psychosis: awareness of illness in schizophrenia and related disorders, 2nd edn. Oxford : Oxford University Press, 2004.